SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Micrologix biotech -- Ignore unavailable to you. Want to Upgrade?


To: Larry G. who wrote (724)6/27/2000 12:41:00 PM
From: Sean Janzen  Respond to of 792
 
Latest Analyst Upgrades / Downgrades (9:45 EST)
Micrologix Biotech Inc. [T.MBI] -$0.15 to $7.10
Micrologix Biotech has been rated 'accumulate' in new coverage from Brian Bapty at Goepel McDermid. The 12-month target was set at $8.00.

stockhouse.ca

I hope they are accurate with their 12 month target because I would like to continue to accumulate.



To: Larry G. who wrote (724)6/28/2000 10:35:00 AM
From: Sean Janzen  Respond to of 792
 
Micrologix successfully completes Phase I clinical trial for the treatment of acne:

biz.yahoo.com